The Feasibility of Florbetapir Quantitation in Europe
NCT02107599
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
Florbetapir (18F)
Sponsor
Avid Radiopharmaceuticals